share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Officer Vittiglio Joseph

bluebird bio | 4:持股变动声明-高管 Vittiglio Joseph

美股SEC公告 ·  02/06 16:13

Moomoo AI 已提取核心信息

Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc., completed a sale of 5,217 shares of common stock on February 5, 2024. The transaction was carried out on the open market with the shares sold at a price of $0.9025 each, resulting in a total sale value of $4,708.34. Following the sale, Vittiglio's direct holdings in the company amount to 44,783 shares of common stock.
Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc., completed a sale of 5,217 shares of common stock on February 5, 2024. The transaction was carried out on the open market with the shares sold at a price of $0.9025 each, resulting in a total sale value of $4,708.34. Following the sale, Vittiglio's direct holdings in the company amount to 44,783 shares of common stock.
蓝鸟生物公司首席商务与法律官约瑟夫·维蒂格里奥于2024年2月5日完成了5,217股普通股的出售。该交易在公开市场上进行,股票以每股0.9025美元的价格出售,总销售价值为4,708.34美元。出售后,维蒂格里奥在该公司的直接持有量为44,783股普通股。
蓝鸟生物公司首席商务与法律官约瑟夫·维蒂格里奥于2024年2月5日完成了5,217股普通股的出售。该交易在公开市场上进行,股票以每股0.9025美元的价格出售,总销售价值为4,708.34美元。出售后,维蒂格里奥在该公司的直接持有量为44,783股普通股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息